Paul Thomen

Friday, 2 August 2013

Construction Aggregates Market Analysis & 2017 Forecast Report



The report Global Construction Aggregates Market – Key Trends and Opportunities to 2017 by Timetric is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Global Construction Aggregates Market – Key Trends and Opportunities to 2017 in subject line and your contact details to purchase this report or get your questions answered.

The global construction aggregates market valued over US$99 billion in 2012, of which the Asia-Pacific region constituted a 42.5% share, making it the largest regional market for construction aggregates in the world. In the same year, Europe and North America were the second- and third-largest regional markets, representing respective shares of 26.9% and 20.8%. Continuing economic uncertainty in Europe and a gradual recovery in the US are expected to reduce these regional market shares. Growing economies in the Asia-Pacific, in particular China, India and Indonesia, are expected to reduce the market shares of Western regions, as the rapid development of infrastructure and other construction markets in these areas increases the demand for construction aggregates. The market shares of the European and North American regions are expected to reach 22.7% and 20% respectively in 2017, down from 2012, while the Asia-Pacific region is forecast to increase its share to 47.6% by 2017.


Scope
This report provides a comprehensive analysis of the construction aggregates market globally:
- Historical (2008-2012) and forecast (2013-2017) valuations of the construction aggregates market in Asia-Pacific, Middle East, Europe, North America, Latin America
- Data provided for construction sands, gravel and pebbles, crushed stones, chippings, waste-based aggregates and pre-coated aggregates
- Breakdown of values at country level (44 countries)
- Analysis of key events and factors driving the construction aggregates market globally

Reasons To Buy
- dentify and evaluate market opportunities using our standardized valuation and forecasting methodologies
- Assess market growth potential at a micro-level via review data and forecasts at category and country level
- Understand the latest industry and market trends
- Formulate and validate business strategies by leveraging our critical and actionable insight
- Assess business risks, including cost and competitive pressures


Key Highlights
The global construction aggregates market valued over US$99 billion in 2012, of which the Asia-Pacific region constituted a 42.5% share, making it the largest regional market for construction aggregates in the world. In terms of growth, the global construction aggregates market recorded a CAGR of 2.40% during the review period. A key factor for this low growth was a decline in the market by 9.8% in 2009.

The Asia-Pacific construction aggregates market valued over US$40 billion in 2012. China constituted the largest share of the regional market with 66.1% in 2012. Future growth will be driven by large-scale infrastructure development undertaken in emerging economies, and the easing of the economic crisis in Europe. However, the slowdown in Asia, the gradual US recovery and uncertainty in Europe will moderate growth.

Crushed stone was the largest category in the market during the review period. The category valued over US$44 billion in 2012, constituting a 44.8% share in the global market. Infrastructure networks in developed countries are well established, and many use lower amounts of aggregates and concrete in construction. The majority of construction work in these countries will be limited to repairs and upgrades of existing infrastructure, and demand for construction aggregates will be less than in emerging nations.

Increasing traffic congestion in urban areas worldwide has forced governments to invest in mass transit projects such as metro railways. GCC nations, in particular, have earmarked large sums of money in the development of a rail network to connect national and regional locations. These developments are expected to drive demand for construction aggregates. Stringent environmental and land use regulations in place in developed countries are expected to boost demand for recycled and secondary construction aggregates (waste-based aggregates) such as blast-furnace slag and crushed hydraulic concrete



Major Points in a Table of Content

9 Company Profile: Vulcan Materials Company
9.1 Vulcan Materials Company - Company Overview
9.2 Vulcan Materials Company - Business Description
9.3 Vulcan Materials Company - Main Products
9.4 Vulcan Materials Company - History
9.5 Vulcan Materials Company - Company Information
9.5.1 Vulcan Materials Company - key competitors
9.5.2 Vulcan Materials Company - key employees
10 Company Profile: CRH Plc
10.1 CRH Plc - Company Overview
10.2 CRH Plc - Business Description
10.3 CRH Plc - Main Products and Services
10.4 CRH Plc - History
10.5 CRH Plc - Company Information
10.5.1 CRH Plc - key competitors
10.5.2 CRH Plc - key employees
11 Company Profile: Martin Marietta Materials, Inc.
11.1 Martin Marietta Materials, Inc. - Company Overview
11.2 Martin Marietta Materials, Inc. - Business Description
11.3 Martin Marietta Materials, Inc. - Main Products
11.4 Martin Marietta Materials, Inc. - History
11.5 Martin Marietta Materials, Inc. - Company Information
11.5.1 Martin Marietta Materials, Inc. - key competitors
11.5.2 Martin Marietta Materials, Inc. - key employees
12 Company Profile: Holcim Ltd
12.1 Holcim Ltd - Company Overview
12.2 Holcim Ltd - Business Description
12.3 Holcim Ltd - Main Products
12.4 Holcim Ltd - History
12.5 Holcim Ltd - Company Information
12.5.1 Holcim Ltd - key competitors
12.5.2 Holcim Ltd - key employees
13 Company Profile: HeidelbergCement AG
13.1 HeidelbergCement AG - Company Overview
13.2 HeidelbergCement AG - Business Description
13.3 HeidelbergCement AG - Main Products
13.4 HeidelbergCement Ag - History
13.5 HeidelbergCement Ag - Company Information
13.5.1 HeidelbergCement AG - key competitors
13.5.2 HeidelbergCement AG - key employees

Impact of Anti-Money Laundering Regulations on Wealth Management 2020 Foresight Report



The report provides a detailed overview of anti-money laundering (AML) initiatives taken by governments and regulatory bodies across the world to combat rapidly growing money laundering activity: Examines the impact of money laundering and how wealth management and other financial institutions have taken measures to deal with such illicit activity; Provides a global perspective on various money laundering activities and the measures being taken to tackle the problem, in terms of enactment of regulations and coordination between nations; Provides an insight into various AML regulatory developments that have taken place in key markets and their impact on their respective governments, financial institutions and customers.


Governments and regulatory bodies have taken numerous measures to curb money laundering activities in the last decade. The phenomenon has assumed increased urgency since 2008-2009 when economies across the world, developed nations in particular, were severely impacted by the financial crisis. Following the global economic slowdown, a number of regulations have been enforced; proposals for the Fourth Money Laundering Directive by the European Commission (EC) in 2013, the launch of new FATF money laundering recommendations in 2012, and the Foreign Account Tax Compliance Act (FATCA) in the US are key recent developments in global AML regulation. These initiatives are intended to strengthen the global AML regulatory environment and increase pressure on financial institutions to comply.

While AML compliance in North America and Europe is highly developed, it is yet to reach these standards in a number of emerging economies in the Asia-Pacific, Middle East and Latin America. While many countries in these regions have formulated AML regulations in the past, effective enforcement by local regulators has been the key challenge. However, governments and regulatory bodies in these nations have demonstrated their interest in bringing their AML compliance in line with international standards. Limited regulatory enforcement and rising money laundering activity have compelled global financial institutions in these economies to take a proactive approach to improve their AML processes, such as know your customer (KYC) and customer due diligence (CDD).


Scope
- This report provides an overview of AML awareness levels and the level of regulatory enforcement in countries across various regions
- Discusses key factors which drive governments and regulatory bodies to formulate and implement AML regulations, and also discusses money laundering activity in key markets
- Outlines the key operational and technological challenges that financial institutions face due to the rapid rise in money laundering activity and frequent regulatory upgrades
- Provides a comprehensive analysis of AML compliance spending trends during the review period (2008-2012) and over the forecast period (2013-2017). The report also provides an overview of market dynamics and key vendors operating in AML
- Outlines the key recommendations provided by the Financial Action Task Force (FATF) to improve AML processes across different countries and financial institutions
- Discusses in detail the best practices adopted by government institutions as well as financial institutions to curb money laundering activities

Reasons To Buy
- Assess the impact of money laundering activities on the global economy and financial system and learn how financial institutions have been taking initiatives to deal with such activities
- Gain insight into various regulatory developments that have been taken place across different markets to combat rising money laundering activities
- Analyze the impact of operational and technological challenges on the business operations of wealth management and other financial institutions caused by these regulatory developments
- Understand the best practices adopted by government bodies and wealth management companies to curb these illicit activities, with the help of case examples



Key Highlights
- The rapid growth of money laundering and other illicit activities has become a major issue for governments and financial institutions across the world.
- Fighting money laundering has become a priority for governments and other international bodies, which are increasingly concerned about the consequences of these illicit activities on corporate governance and business operations in the financial sector, as well as the overall fundamentals of the world economy.
- Governments and regulatory bodies across the world have been tightening regulations to combat money laundering. Economies such as the US, the UK, Germany, Australia, Japan and Singapore have strong AML regulations in place, while Canada, Brazil, Russia, India and China are taking initiatives to introduce AML regulations.
- Financial institutions face a number of operational and technological challenges due to changes in regulations. These entail increased regulatory complexity and improvements in IT systems, documentation and record keeping. Reduced customer privacy is also expected to be a rising concern, due to increasing disclosure and information sharing requirements.


Major Points in a Table of Content

7 Best Practices in AML Compliance
7.1 Key Recommendations
7.1.1 AML/CFT policies and coordination
7.1.2 Money laundering and confiscation
7.1.3 Terrorist financing and financing of proliferation
7.1.4 Preventive measures
7.1.5 Transparency and beneficial ownership of legal persons and arrangements
7.1.6 Powers and responsibilities of competent authorities and other institutional measures
7.1.7 International cooperation
7.2 Case Examples
7.2.1 Wegelin & Co.'s non-adherence to AML regulations
7.2.2 Adoption of software by Capital Bank to counter money laundering
7.2.3 Bank Central Asia (BCA) selects NICE Actimize to improve its AML processes
7.2.4 Central Bank penalized three Indian banks for violating KYC regime
7.2.5 US authorities charged HSBC with violating CDD requirements

Opportunities in Human Embryonic Stem Cell Products Market



The report Opportunities in Human Embryonic Stem Cell Products by BioInformant Worldwide, L.L.C. is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Opportunities in Human Embryonic Stem Cell Products in subject line and your contact details to purchase this report or get your questions answered.

Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. Human embryonic stem cells are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body.

Human embryonic stem cells were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived from human blastocysts. Federal funds to support hESC research became available on August 9, 2001, when President Bush announced his decision regarding federal funding for hESC research.


Because of their plasticity and unlimited capacity for self-renewal, hESCs have been proposed for use in wide range of applications, including toxicology testing, tissue engineering, cellular therapies, and basic stem cell biology research. Of particular interest to the medical community is the potential for use of hESCs to heal tissues with naturally limited capacity for renewal, such as the human heart, liver and brain.

However, human embryonic stem cell research is heavily encumbered by patents held by the University of Wisconsin’s Wisconsin Alumni Research Foundation (WARF), which creates significant challenges for companies seeking to develop new products.

This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives – such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species.


Key Findings Include:
- Trends for hESC Grants, Scientific Publications, and Patents
- Market Size Determination for the hESC Product Market
- 5-Year Market Size Projections (2013-2017)
- Embryonic Stem Cell Patent Restrictions and Strategies to Circumvent Claims
- Geographical Breakdown (Leading Countries Conducting hESC Research)
- Breakdown of Embryonic Stem Cell Research, by Application and Species
- Competitive Analysis of hESC Research Supply Vendors
- Overview of Specialty Pharma Companies Developing Embryonic Stem Cell Therapies
- Overview of Toxicology Testing Legislation (impacting use of hESC in toxicology applications)
- Crucial Trends and Unmet Market Needs
- And Much More

The potential medical advances made possible from the use of human embryonic stem cells (hESC) are huge, so it is no surprise that the scientific research community is enthusiastically exploring all possibilities.
Where there is significant and growing interest from scientists, there is an opportunity to increase revenue from hESC products. There is no doubt it’s an exciting market in which to expand your product range, but with embryonic stem cells there are serious market entry barriers to consider – namely a complex intellectual property scene.

This report will help you understand the market entry challenges you face and give you the expert advice to overcome them. Couple this with market leading intelligence data and this report is a must have if you’re looking to outcompete your rivals in this expanding and highly profitable market.


Navigating the Intellectual Property Landscape: Making the Complex Simple
Human embryonic stem cell research is restricted by patents held by the University of Wisconsin’s Wisconsin Alumni Research Foundation (WARF), which creates significant challenges for companies looking to develop products to supply this part of the stem cell research market.

The intellectual property (IP) issues for companies wishing to enter the market are such a barrier to entry that knowledge of how to overcome the problem becomes extremely valuable. The complex IP landscape requires specialist industry knowledge to help you navigate the legal and commercial challenges you will face. With simple and expert advice, you will understand:
- The background of the patent landscape
- The licensing of WARF patent rights
- WARF patent exceptions
- How to circumvent WARF patents rights through geographic limitations
- The global stem cell patent landscape
- And much more

Explorer More Reports of Medical Devices Market @ http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices

Major Points in a Table of Content

VII. hESC Product Competitors
A. Cellartis AB
1. Human embryonic stem cell lines
2. Monoclonal Antibodies for hESC Research
3. Differentiated Cell Products
4. Associated hESC products
B. Vitrolife
C. Tataa Biocenter
D. Invitrogen
1. hESC Culture Media & Reagents
2. hESC-qualified Basement Membrane Extract
3. hESC cDNA Libraries
4. hESC Reporter Cells
5. hESC PCR Kits
6. hESC Stem Cell Antibodies
7. hESC Stem Cell Growth Factors
E. Stem Cell Technologies
1. hESC Culture Media & Reagents
2. hESC Primary & Secondary Antibodies
F. BD Biosciences
G. Chemicon
1. hESC Culture Media and Reagents
2. hESC Lines
3. hESC Kits
4. hESC Antibodies
H. R&D Systems
I. SA Biosciences
J. Thermo Scientific
K. Australian Stem Cell Centre